PPARA and non-small cell lung carcinoma: These pathways contained PPAR signaling pathway, arachidonic acid metabolism, metabolism of xenobiotics by cytochrome P450, steroid hormone biosynthesis, chemical carcinogenesis, bile secretion, metabolic pathways, linoleic acid metabolism, thyroid cancer, insulin resistance, hepatitis C, non-small cell lung cancer, and nonalcoholic fatty liver disease (NAFLD).